Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
drugs
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
3
×
san diego blog main
san diego top stories
akcea therapeutics
clinical trials
fda
inotersen
onpattro
patisiran
tafamidis
4d molecular therapeutics
abbvie
acne
agenus
alnylam pharmaceuticals
anylam pharmaceuticals
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
What
drug
fda
3
×
alnylam
approved
disease
ago
akcea
amyloidosis
approves
attr
available
battle
bio
cells
companies
debilitating
digital
ema
employ
epidemic
europe
fatty
follows
frenzied
gene
genetic
growing
harmful
hits
interference
known
led
liver
make
medicine
medicines
merck
method
mute
nash
Language
Current search:
fda
×
drugs
×
pfizer
×
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug